Lu Ming-fong, president and CEO of Targetgen Biotechnology Co., points out that his company is currently not ready to advocate screening for mutant genes that cause liver cancer, because there is no treatment for this disease. Lu says, "Once you identify the gene, what are you supposed to do?
創盛基因科技總經理呂銘峰指出，目前他們還不願意積極推廣肝癌變異基因的篩檢，原因正是沒有對治的方法，「檢查出來又如何？